M. Hayat

ACTIVE IMMUNOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKÆMIA

G Mathé, Jeanne Amiel, L Schwarzenberg et al. · The Lancet · 1969 · 612 citations

Immunosuppressive Therapy, Immunology, Hematology +6

Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group.

Bob Löwenberg, Stefan Suciu, E Archimbaud et al. · Journal of Clinical Oncology · 1998 · 288 citations · Full text

Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987

M Tubiana, M. Henry‐Amar, Patrice Carde et al. · Blood · 1989 · 261 citations · Full text

Adriamycin cardiotoxicity: a survey of 1273 patients.

C Praga, G. Beretta, Vigo Pl et al. · PubMed · 1979 · 248 citations

Ecg Monitoring, Heart Failure, Oncology +13

Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: the H6 twin randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group.

Patrice Carde, Anton Hagenbeek, M. Hayat et al. · Journal of Clinical Oncology · 1993 · 209 citations